Sigma-Aldrich Announces Agreement with Public Health England to Manufacture and Supply NCTC/NCPF Certified Reference Materials

Aug 27, 2015, 07:00 ET from Sigma-Aldrich Corporation

ST. LOUIS, Aug. 27, 2015 /PRNewswire/ -- Sigma-Aldrich Corporation (NASDAQ: SIAL), a leading Life Science and Technology Company, today announced it has signed an agreement with Public Health England (PHE) to manufacture and supply bacterial and fungal NCTC/NCPF Certified Reference Materials (CRM) in LENTICULE® disc format worldwide for use as controls in food, water, environmental and clinical testing microbiology laboratories.

"Sigma-Aldrich is excited to offer the global scientific community access to the LENTICULE disc portfolio," said Trevor Jones, Vice President for the Sigma-Aldrich Analytical Business. "The addition of these certified reference materials supports our aim to offer a broad portfolio of products that accelerate customers' confidence in the quality and accuracy of analytical data."

Each CRM LENTICULE disc consists of a stipulated level of a pure culture of viable bacteria or fungi in a control-dried water-soluble matrix. The bacterial and fungal strains are prepared directly from strains selected from PHE's National Collection of Type Cultures (NCTC) and National Collection of Pathogenic Fungi (NCPF).

"Our agreement with Sigma-Aldrich will enable more scientists worldwide to easily access the NCTC/NCPF CRMs," said Julie Russell, Head of PHE's Culture Collections. "Licensing the LENTICULE disc technology to Sigma-Aldrich means the PHE microbiologists can concentrate on the development of new products to improve health outcomes, while end users benefit from Sigma-Aldrich's expertise in manufacturing and global distribution."

The CRMs will be produced in accordance with ISO Guide 34 and individually packed at Sigma-Aldrich for customer convenience. "We have invested in a new, dedicated Biosafety Level 2 facility and expanded the scope of our ISO 17025/ ISO Guide 34 accreditation to manufacture this product range in full accordance with our Environmental Health and Safety (EHS) and quality guidelines," said Fabian Wahl, Ph.D., Business Development Director at Sigma-Aldrich.

For more information on Sigma-Aldrich's NCTC/NCPF CRMs in LENTICULE disc format, visit www.sigma.com/lenticules.

Cautionary Statement: The foregoing release contains forward-looking statements that can be identified by terminology such as "will enable," "will be produced" or similar expressions, or by expressed or implied discussions regarding potential future revenues from products derived there from. You should not place undue reliance on these statements. Such forward-looking statements reflect the current views of management regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. There can be no guarantee that this or any other license agreement will assist the Company to achieve any particular levels of revenue in the future. In particular, management's expectations regarding this license agreement could be affected by, among other things, the Company's ability to obtain or maintain patent or other proprietary intellectual property protection; competition in general; government, industry and general public pricing pressures; the impact that the foregoing factors could have on the values attributed to the Company's assets and liabilities as recorded in its consolidated balance sheet, and other risks and factors referred to in Sigma-Aldrich's current Form 10-K on file with the US Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, believed, estimated or expected. Sigma-Aldrich is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.

About Sigma-Aldrich:  Sigma-Aldrich, a leading Life Science and Technology company focused on enhancing human health and safety, manufactures and distributes 250,000 chemicals, biochemicals and other essential products to more than 1.4 million customers globally in research and applied labs as well as in industrial and commercial markets. With three distinct business units - Research, Applied and SAFC Commercial - Sigma-Aldrich is committed to enabling science to improve the quality of life. The Company operates in 37 countries, has 9,700 employees worldwide and had sales of $2.79 billion in 2014. For more information about Sigma-Aldrich, please visit its website at www.sigma-aldrich.com.

Sigma-Aldrich and Sigma are trademarks of Sigma-Aldrich Co, LLC registered in the US and other countries. LENTICULE is a trademark of The Secretary of State for Health, registered in the UK, the US and other countries.

 

SOURCE Sigma-Aldrich Corporation



RELATED LINKS

http://www.sigma-aldrich.com